from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2428/ahpC

LFCtreatmentdescriptionclass of inhibitor

-0.263

Amikacinug/mL Amikacintranslation

0.028

Cap5-10ug/mL Capreomycintranslation

0.597

Rox10-50 ug/mL Roxithromycintranslation

0.988

SM2-5 ug/mL Streptomycintranslation

-0.509

Tet5-10 ug/mL Tetracyclinetranslation

-0.712

Rif0.2-5ug/mL Rifampicintranscription

0.784

Rifp0.1-0.5ug/mL Rifapentinetranscription

-3.103

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.664

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-1.012

CPZ10-50 ug/mL Chlorpromazinerespiration

1.170

Clofazimine10-13 ug/mL Clofaziminerespiration

0.444

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.846

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.085

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.822

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.840

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.953

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.737

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.808

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.095

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.638

KCN5-20 ug/mL Potassium cyaniderespiration

1.189

NaN30.2-2 mM Sodium aziderespiration

2.054

Nigericin50 uM Nigericinrespiration

-0.804

TRC10-150 ug/mL Triclosanrespiration

-1.531

TRZ10-25 ug/mL Thioridazinerespiration

-0.409

Valinomycin0.5-10 uM Valinomycinrespiration

0.198

ZnSO42 mM ZnSO4respiration

-0.250

menadione6-10 ug/mL Menadionerespiration

1.172

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.380

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.418

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.168

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.216

NRP_1Non-replicating persistence stage 1dosRassociated

0.030

Amp0.2mg/mL AmpicillincellWall

-0.085

Cephalexin20-100 ug/mL CephalexincellWall

1.519

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.017

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.334

EMB10-20 ug/mL EthambutolcellWall

1.367

Eta12-40 ug/mL EthionamidecellWall

0.907

INH0.2-0.4 ug/mL IsoniazidcellWall

0.501

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.620

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.580

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.196

BZA0.12 mg/mL BenzamidearomaticAmides

-0.611

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.951

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.555

H2O24 mM hydrogen peroxideDNAdamaging

-0.319

Levo10 ug/mL LevofloxacinDNAdamaging

0.560

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.178

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.190

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.303

UVUV-irradiationDNAdamaging

-0.754

ARP41-4 ug/mL Antitubercular compound ARP4?

0.035

Antimycin12.5-50 ug/mL Antimycin A?

-0.396

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.003

PA_110-50 ug/mL Antitubercular compound PA-1?

1.203

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.765

PA8240.2-2 ug/mL PA-824?

0.627

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.377

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.542

Verapamil50 uM Verapamil?

0.521

mercaptoethanol2 mM 2-Mercaptoethanol?

0.307

methoxatin10-20 ug/mL Methoxatin?